Patents by Inventor Angus Gidley-Baird

Angus Gidley-Baird has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
    Patent number: 9181320
    Abstract: The invention relates to purinergic (P2X) receptors, more specifically to P2X7 receptors, the generation of antibodies and the use of antibodies and immunogens that are capable of selectively binding to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor, for the detection and treatment of disease conditions, especially cancer.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 10, 2015
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antibodies to Non-Functional P2X7 Receptor
    Publication number: 20150274839
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Application
    Filed: May 29, 2015
    Publication date: October 1, 2015
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antibodies to Non-Functional Oligomeric P2X7 Receptors
    Publication number: 20150218283
    Abstract: The invention relates to purinergic receptors, to antibodies and related fragments thereof for binding to said receptors, to production of said antibodies and fragments and to sue of said antibodies and fragments for cancer detection and therapy. In particular the antibodies described bind specifically to non-functional P2X& receptors expressed by live cells.
    Type: Application
    Filed: August 11, 2014
    Publication date: August 6, 2015
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander Barden, Angus Gidley-Baird, Glenn Ronald Pilkington
  • Combination Therapy
    Publication number: 20150004179
    Abstract: The invention relates to producing humoral response to P2X7 receptors in individuals having cancer, and to minimizing the progression of cancer in said individuals.
    Type: Application
    Filed: July 2, 2012
    Publication date: January 1, 2015
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antibodies To Non-Functional P2X7 Receptor
    Publication number: 20140323693
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between functional and non-functional p2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Application
    Filed: March 18, 2014
    Publication date: October 30, 2014
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof
    Patent number: 8835609
    Abstract: The invention relates to purinergic receptors, to antibodies and related fragments thereof for binding to said receptors, to production of said antibodies and fragments and to use of said antibodies and fragments for cancer detection and therapy. In particular the antibodies described bind specifically to non-functional P2X7 receptors expressed by live cells.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 16, 2014
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird, Glenn Ronald Pilkington
  • ANTIBODIES FOR BINDING TO NON-FUNCTIONAL P2X7 RECEPTORS IN TRIMERIC FORM
    Publication number: 20140135475
    Abstract: The invention relates to a novel epitope on P2X7 receptors, to antibodies for binding to the epitope and to peptides for generating the antibodies.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 15, 2014
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: JULIAN ALEXANDER BARDEN, ANGUS GIDLEY-BAIRD
  • Antibodies to non-functional P2Xreceptor
    Patent number: 8709425
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: April 29, 2014
    Assignee: Biosceptre International Limited
    Inventors: Julia Alexander Barden, Angus Gidley-Baird
  • Purinergic (P2X) receptors in extra-cellular body fluid
    Patent number: 8658385
    Abstract: The invention relates to purinergic (P2X) receptors, to detection of protein in extra-cellular body fluids and to anti-bodies for the diagnosis or condition, especially cancer.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: February 25, 2014
    Assignee: Biosceptre International Limited
    Inventors: Angus Gidley-Baird, Julian Alexander Barden
  • Antibodies for binding to non-functional P2Xreceptors in trimeric form
    Patent number: 8597643
    Abstract: The invention relates to the identification of a novel epitope on non-functional P2X7 receptors which are implicated in cancer. The epitope includes a region from two adjacent monomers within the three subunit receptor. Antibodies which bind to the epitope and peptides for generating the antibodies are described. The antibodies and peptides are useful in the diagnosis and treatment of cancer.
    Type: Grant
    Filed: July 3, 2009
    Date of Patent: December 3, 2013
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Novel P2X7 Epitopes
    Publication number: 20130273085
    Abstract: The invention relates to purinergic (P2X) receptors, more specifically to P2X7 receptors, the generation of antibodies and the use of antibodies and immunogens that are capable of selectively binding to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor, for the detection and treatment of disease conditions, especially cancer.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • COMPANION ANIMAL TREATMENTS
    Publication number: 20130266592
    Abstract: The invention relates to minimising the progression of cancer in a companion animal using P2X7 immunotherapy.
    Type: Application
    Filed: September 9, 2011
    Publication date: October 10, 2013
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antibodies To Non-Functional P2X7 Receptor
    Publication number: 20130245226
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Application
    Filed: February 13, 2013
    Publication date: September 19, 2013
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander BARDEN, Angus Gidley-Baird
  • Purinergic (P2X) Receptors in Extra-Cellular Body Fluid
    Publication number: 20130171666
    Abstract: The invention relates to purinergic (P2X) receptors, to detection of protein in extra-cellular body fluids and to anti-bodies for the diagnosis or condition, especially cancer.
    Type: Application
    Filed: September 25, 2012
    Publication date: July 4, 2013
    Applicant: Biosceptre International Limited
    Inventors: Angus Gidley-Baird, Julian Alexander Barden
  • P2X7 epitopes
    Patent number: 8440186
    Abstract: The invention relates to purinergic (P2X) receptors, more specifically to P2X7 receptors, the generation of antibodies and the use of antibodies and immunogens that are capable of selectively binding to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor, for the detection and treatment of disease conditions, especially cancer.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: May 14, 2013
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Non-functional P2Xreceptor
    Patent number: 8399617
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: March 19, 2013
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Antibodies to Non-Functional Oligomeric P2X7 Receptors
    Publication number: 20120329076
    Abstract: The invention relates to purinergic receptors, to antibodies and related fragments thereof for binding to said receptors, to production of said antibodies and fragments and to use of said antibodies and fragments for cancer detection and therapy. In particular the antibodies described bind specifically to non-functional P2X7 receptors expressed by live cells.
    Type: Application
    Filed: December 23, 2010
    Publication date: December 27, 2012
    Applicant: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Purinergic (P2X) receptors in extra-cellular body fluid
    Patent number: 8293491
    Abstract: The invention relates to purinergic (P2X) receptors, to detection of protein in extra-cellular body fluids and to antibodies for the diagnosis of a disease or condition, especially cancer.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: October 23, 2012
    Assignee: Biosceptre International Limited
    Inventors: Angus Gidley-Baird, Julian Alexander Barden
  • Non-Functional P2X7 Receptor
    Publication number: 20120059151
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Application
    Filed: November 16, 2011
    Publication date: March 8, 2012
    Applicant: BIOSCEPTRE INTERNATIONAL LIMITED
    Inventors: Julian Alexander Barden, Angus Gidley-Baird
  • Non-functional P2Xreceptor
    Patent number: 8080635
    Abstract: The present invention provides antibodies that specifically bind to P2X7 receptors and distinguish between function and non-functional P2X7 receptors, pharmaceutical compositions and kits containing the antibodies, and methods of using the antibodies for the detection, diagnosis and treatment of disease conditions.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: December 20, 2011
    Assignee: Biosceptre International Limited
    Inventors: Julian Alexander Barden, Angus Gidley-Baird